Vanda Pharmaceuticals' (VNDA) CEO Mihales Polymeropoulos on Q4 2019 Results - Earnings Call Transcript [Seeking Alpha]
Vanda Pharmaceuticals Inc. (VNDA)
Last vanda pharmaceuticals inc. earnings: 2/25 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
phx.corporate-ir.net/phoenix.zhtml?c=196233&p=irol-irhome
Company Research
Source: Seeking Alpha
Vanda Pharmaceuticals Inc. (NASDAQ: VNDA Company Participants Mihales Polymeropoulos – President and Chief Executive Officer AJ Jones – Chief-Corporate Affairs Kevin Moran – Vice President and Controller Conference Call Participants Chris Howerton – Jefferies Shawn Egan – Citi Operator Ladies and gentlemen, thank you for standing by, and welcome to the Vanda Pharmaceuticals Fourth Quarter 2019 Earnings Conference Call. At this time, all participants’ lines are in a listen-only mode. After the speakers’ presentation, there will be a question-and-answer session. [Operator Instructions] Please be advised that today’s conference is being recorded. [Operator Instructions] I would now like to hand the conference over to your speaker today, Mr. Kevin Moran, Vice President and Controller. Please go ahead, sir. Good afternoon. This isn’t Kevin. This is AJ Jones, Chief-Corporate Affairs Officer, but thank you so much Liz for that setup. I do appreciate it. Good afternoon, everyone, and thank yo
Show less
Read more
Impact Snapshot
Event Time:
VNDA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VNDA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VNDA alerts
High impacting Vanda Pharmaceuticals Inc. news events
Weekly update
A roundup of the hottest topics
VNDA
News
- Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.MarketBeat
- New Strong Buy Stocks for November 14th [Yahoo! Finance]Yahoo! Finance
- Vanda Pharmaceuticals Announces Participation at November 2024 Investor Conferences [Yahoo! Finance]Yahoo! Finance
- Vanda Pharmaceuticals Announces Participation at November 2024 Investor ConferencesPR Newswire
- Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.MarketBeat
VNDA
Earnings
- 11/6/24 - Beat
VNDA
Analyst Actions
- 10/31/24 - HC Wainwright
VNDA
Sec Filings
- 11/18/24 - Form 4
- 11/14/24 - Form 144
- 11/7/24 - Form 10-Q
- VNDA's page on the SEC website